Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas

Fig. 2

Treatment schedule of IACRT combined with systemic cetuximab administration. IACT: intra-arterial chemotherapy, Cisplatin (C): 5 mg/m2/day (Total: 150 mg/m2/6 weeks), Docetaxel (D): 10 mg/m2/week (Total: 60 mg/m2/6 weeks), RT: Radiotherapy, 2 Gy/day (Total: 60 Gy), C-mab: cetuximab, initial dose at 400 mg/m2, followed by the dose at 250 mg/m2 (Total: 1900 mg/m2/7 weeks)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us